These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
984 related items for PubMed ID: 27116012
21. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Perez RO, Habr-Gama A, São Julião GP, Gama-Rodrigues J, Sousa AH, Campos FG, Imperiale AR, Lynn PB, Proscurshim I, Nahas SC, Ono CR, Buchpiguel CA. Int J Radiat Oncol Biol Phys; 2012 Dec 01; 84(5):1159-65. PubMed ID: 22580120 [Abstract] [Full Text] [Related]
22. Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer. Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T. Dis Colon Rectum; 2018 Mar 01; 61(3):320-327. PubMed ID: 29360680 [Abstract] [Full Text] [Related]
24. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ. Am J Clin Oncol; 2012 Aug 01; 35(4):340-4. PubMed ID: 21422901 [Abstract] [Full Text] [Related]
25. The reduction of 18F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression. Wu F, Zhang X, Yang C, Wang K, Xiao L, Zhou C, Zhao X, Wang G. Front Oncol; 2022 Aug 01; 12():1037783. PubMed ID: 36620536 [Abstract] [Full Text] [Related]
28. Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer. Saito G, Sadahiro S, Ogimi T, Miyakita H, Okada K, Tanaka A, Suzuki T. Oncology; 2018 Aug 01; 94(3):167-175. PubMed ID: 29268274 [Abstract] [Full Text] [Related]
30. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Sakin A, Sahin S, Karyagar SS, Karyagar S, Atci M, Akboru MH, Cihan S. J Gastrointest Cancer; 2022 Jun 01; 53(2):341-347. PubMed ID: 33651265 [Abstract] [Full Text] [Related]
31. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer. Bang JI, Ha S, Kang SB, Lee KW, Lee HS, Kim JS, Oh HK, Lee HY, Kim SE. Eur J Nucl Med Mol Imaging; 2016 Mar 01; 43(3):422-31. PubMed ID: 26338180 [Abstract] [Full Text] [Related]
32. Prediction of Response to Neoadjuvant Chemotherapy and Radiation Therapy with Baseline and Restaging 18F-FDG PET Imaging Biomarkers in Patients with Esophageal Cancer. Beukinga RJ, Hulshoff JB, Mul VEM, Noordzij W, Kats-Ugurlu G, Slart RHJA, Plukker JTM. Radiology; 2018 Jun 01; 287(3):983-992. PubMed ID: 29533721 [Abstract] [Full Text] [Related]
33. Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer. Stiekema J, Vermeulen D, Vegt E, Voncken FE, Aleman BM, Sanders J, Boot H, van Sandick JW. Clin Nucl Med; 2014 Oct 01; 39(10):862-7. PubMed ID: 25140549 [Abstract] [Full Text] [Related]
34. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D. Eur J Nucl Med Mol Imaging; 2007 Oct 01; 34(10):1583-93. PubMed ID: 17503039 [Abstract] [Full Text] [Related]